Original article by Jamie Walker, Sarah Petty
The Australian – Page: 3 : 27-Jun-22

The BA.4 and BA.5 subvariants of Omicron are rapidly becoming the dominant strains of COVID-19 in Australia. They are better able to evade existing vaccines, but companies such as Pfizer and Moderna have indicated that they have had some success in developing vaccines that target these variants. While Australians who meet certain criteria can now receive a second booster dose, health authories may delay recommending a broader rollout until vaccines that target these variants are available. Victorian Premier Daniel Andrews is amongst those who support this view; the state recorded 5,824 new COVID-19 cases and 15 deaths on Sunday. There were 7,461 new infections and seven deaths in NSW.

CORPORATES
PFIZER INCORPORATED, MODERNA INCORPORATED, VICTORIA. DEPT OF PREMIER AND CABINET